99--MEDICALXREAGENTXPAC

The Department of Defense's DLA Troop Support Indo-Pacific is seeking to establish a Simplified Indefinite-Delivery Contract with a commercial firm to supply Class VIII Medical Leuko Reagents for the U.S. Naval Hospital in Okinawa, Japan. These reagents are essential for diagnostic testing and patient care for active duty service members, their families, and other eligible beneficiaries. The contract will cover procurement and delivery of these critical supplies, with all required items detailed in the attached Schedule of Items for fiscal years 2026 through 2028. Interested vendors are encouraged to submit their complete proposals, including signed documentation, pricing for the base period and two optional one-year periods, and necessary certifications, by September 29, 2025, via email. The solicitation emphasizes the importance of timely and complete responses to be considered for award, with the contract managed under NAICS code 325412. The primary point of contact is Eric Guidish, reachable through email for inquiries or submission of proposals. The contract aims to ensure a reliable supply of vital medical reagents to support medical operations at the Okinawa facility, reinforcing the Department of Defense’s commitment to maintaining high-quality healthcare for its personnel and beneficiaries in the region.